Academic Journal

Office-Based Procedures for Chronic Cough.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Office-Based Procedures for Chronic Cough.
Συγγραφείς: Perryman MC; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: mcperryman@uabmc.edu., Simpson CB; Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Πηγή: Otolaryngologic clinics of North America [Otolaryngol Clin North Am] 2026 Aug; Vol. 59 (4), pp. 831-840. Date of Electronic Publication: 2026 May 29.
Τύπος έκδοσης: Journal Article; Review
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: W B Saunders Country of Publication: United States NLM ID: 0144042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8259 (Electronic) Linking ISSN: 00306665 NLM ISO Abbreviation: Otolaryngol Clin North Am Subsets: MEDLINE
Imprint Name(s): Publication: Philadelphia Pa : W B Saunders
Original Publication: Philadelphia, Saunders.
Ιατρικοί όροι (MeSH): Chronic Cough*/therapy , Chronic Cough*/etiology , Nerve Block*/methods , Botulinum Toxins, Type A*/administration & dosage , Cough*/therapy, Laryngeal Nerves/drug effects ; Humans ; Vocal Cords ; Treatment Outcome
Περίληψη: Refractory chronic cough is a common and challenging condition that results from laryngeal hypersensitivity. Office-based procedures can serve as adjuncts to behavioral or medical therapies or as alternatives for patients with incomplete response or intolerance to these treatments. This article reviews the rationale, techniques, and outcomes of three office-based interventions: superior laryngeal nerve block, laryngeal botulinum toxin injection, and vocal fold injection augmentation. These procedures are safe, cost-effective, and well-tolerated in the clinic setting.
(Copyright © 2026 Elsevier Inc. All rights reserved.)
Competing Interests: Disclosure The authors having nothing to disclose.
Contributed Indexing: Keywords: Botulinum toxin; Chronic cough; In-office procedures; Laryngeal hypersensitivity; Neurogenic cough; Superior laryngeal nerve block; Vocal fold injection
Substance Nomenclature: EC 3.4.24.69 (Botulinum Toxins, Type A)
Entry Date(s): Date Created: 20260529 Date Completed: 20260708 Latest Revision: 20260708
Update Code: 20260708
DOI: 10.1016/j.otc.2026.03.022
PMID: 42215346
Βάση Δεδομένων: MEDLINE